Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697064 | Brachytherapy | 2017 | 5 Pages |
Abstract
Patients with a PSAD of <0.15Â ng/mL/cm3 have little risk of BF, even in the case of a suboptimal implant. These results need to be validated in other patients' cohorts.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
David Benzaquen, Guila Delouya, Cynthia Ménard, Maroie Barkati, Daniel Taussky,